雌细胞体和不孕症:对诊断和治疗的影响
Sareh Bakhshandeh Bavarsad1, Soroosh Shahryarhesami2, Noorodin Karami1
1Genetics Department, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Journal of reproductive immunology
|December 4, 2024
概括
细胞化,即亡细胞的清除,对于生育至关重要. 它的失调有助于不孕,流产和植入失败,影响男性和女性的生殖健康.
科学领域:
- 生殖生物学 生殖生物学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 清除亡细胞的过程Efferocytosis,越来越多地被认为是其在生殖健康中的作用.
- 细胞的失调与各种不孕症原因和生殖系统疾病有关.
- 细胞亡的细胞清除在女性生殖系统和男性精子生成中都至关重要.
研究的目的:
- 在不孕不育的背景下,提供对雌激细胞酶的全面审查.
- 阐明与生殖健康相关的细胞酶的分子机制.
- 讨论对男性和女性不孕不育的雌激细胞酶失调的影响.
主要方法:
- 关于细胞和不孕不育的研究的文献综述.
- 分析了背后的分子机制的Efferocytosis.
- 检查了在生殖疾病和辅助生殖技术中雌激细胞的作用.
主要成果:
- 不足够的乙细胞形成导致低怀孕率,流产和植入失败.
- 在男性中,有缺陷的雌激细胞分裂会通过巨细胞和塞尔托利细胞的受损的亡性生殖细胞清除影响精子生成.
- 损坏的细胞质损害了植入,导致经常性流产和不成功的辅助生殖.
结论:
- 生殖细胞分裂是维持生殖健康的关键因素.
- 功能障碍性雌激细胞分裂是各种形式的不孕症的重要原因之一.
- 了解细胞酶的机制可以改善生殖障碍的诊断和治疗策略.
相关概念视频
Infertility in Males
242
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
242
Infertility in Females
275
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
275
Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
Meiosis II
182.8K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
182.8K
In Vitro Fertilization
216
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
216
The Early Endosome: Endocytosis of Transferrin
3.2K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.2K


